During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

Antibody-drug conjugate (ADC) specialist Seagen has claimed its ... as a second-line monotherapy for recurrent or metastatic cervical cancer. The accelerated approval for Tivdak (tisotumab vedotin ...

He expressed concern that every year in Nigeria, more than 12,000 women suffer from cervical cancer, saying the disease is preventable. Prof. Pate noted that President Bola Tinubu was committed to ...

Each year, millions of people attend cervical screening appointments to help prevent cervical cancer, the most common cancer in women under 35 years old. However, many don’t come forward and ...

MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

A pelvic magnetic resonance image (MRI) showed a cervical lesion of 2.5 cm in diameter, without parametrial invasion, compatible with the clinical cervical carcinoma FIGO stage IB 1. Because the ...

Compared with women with ASC-US, the results of women with ASC-H on routine Pap are much more likely to have moderate to severe CIN, with estimates ranging widely from 24% to 94%. As a result ...

Design and settings Cost savings focussed on where evidence of health benefit is strongest: reductions in gastrointestinal and lower respiratory tract infections, acute otitis media in infants, ...